Chronic Kidney Disease Stages

When patients receive a diagnosis of chronic kidney disease from their primary care physician, they are typically sent to a nephrologist for further care.

The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.

Researchers identified significant differences in eGFR and measured eGFR on an individual level, according to data published in Annals of Internal Medicine.

Patients with stage 3 to 4 chronic kidney disease prefer prebiotic and probiotic supplements that are flexible and easily integrated into daily routines, according to data published in the Journal of Renal Nutrition.

Patients with chronic kidney disease are more willing to assume some risks of new medication as their disease advances, according to data published in Kidney Medicine.

Researchers successfully used electronic health record data to measure and identify risk factors of chronic kidney disease progression in a large cohort of pediatric patients, according to a speaker at ASN Kidney Week.

Patients with chronic kidney disease are not at an increased risk for AKI or death after chimeric antigen receptor T-cell therapy, according to a speaker at ASN Kidney Week.

Panelists opened 2021 ASN Kidney Week by discussing the impact that the COVID-19 virus can have on chronic kidney disease, in addition to how vaccinating vulnerable populations is the best way to end the pandemic.

The diagnostic criteria for chronic kidney disease that uses the standard estimated glomerular filtration rate threshold of 60 mL/min/1.73 m2 regardless of one’s age may lead to overdiagnosis, researchers wrote.